Insider Transactions in Q4 2021 at Outset Medical, Inc. (OM)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-3.81%
|
$940,000
$47.24 P/Share
|
|
Dec 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.65%
|
$60,000
$3.41 P/Share
|
|
Dec 01
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-18.87%
|
$164,500
$47.92 P/Share
|
|
Dec 01
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+15.88%
|
$31,500
$9.48 P/Share
|
|
Dec 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Indirect |
1,296
-19.99%
|
$60,912
$47.92 P/Share
|
|
Nov 16
2021
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,467
-7.86%
|
$125,817
$51.69 P/Share
|
|
Nov 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
4,945
-13.82%
|
$252,195
$51.29 P/Share
|
|
Nov 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,945
+11.97%
|
$44,505
$9.48 P/Share
|
|
Nov 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
35,000
-6.52%
|
$1,960,000
$56.24 P/Share
|
|
Nov 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+6.11%
|
$70,000
$2.93 P/Share
|
|
Nov 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,500
-38.17%
|
$644,000
$56.22 P/Share
|
|
Nov 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+27.59%
|
$34,500
$3.88 P/Share
|
|
Nov 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Indirect |
3,888
-20.83%
|
$209,952
$54.66 P/Share
|
|
Oct 22
2021
|
Stacey L. Porter Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,499
+10.14%
|
-
|
|
Oct 19
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,445
-8.76%
|
$72,250
$50.0 P/Share
|
|
Oct 19
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,445
+8.06%
|
$13,005
$9.48 P/Share
|
|
Oct 15
2021
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,500
-18.87%
|
$171,500
$49.02 P/Share
|
|
Oct 15
2021
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+15.88%
|
$31,500
$9.48 P/Share
|
|
Oct 01
2021
|
D Keith Grossman Director |
SELL
Open market or private sale
|
Direct |
1,296
-19.69%
|
$63,504
$49.69 P/Share
|
|
Oct 01
2021
|
D Keith Grossman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62
+1.82%
|
$62
$1.11 P/Share
|
|
Oct 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
42,500
-5.33%
|
$2,040,000
$48.7 P/Share
|
|
Oct 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+5.04%
|
$85,000
$2.93 P/Share
|
|
Oct 01
2021
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,000
-36.49%
|
$768,000
$48.71 P/Share
|
|
Oct 01
2021
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+26.72%
|
$48,000
$3.88 P/Share
|